Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantine Mitsiades

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Future Oncology (London, England)|March 25, 2006
Bortezomib: proteasome inhibition as an effective anticancer therapyPaul G Richardson, Constantine Mitsiades
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
Autologous stem cell transplantation and multiple myeloma cancer stem cellsWilliam Matsui, Ivan Borrello, Constantine Mitsiades
Oncology (Williston Park, N.Y.)|May 30, 2009
Maximizing the clinical benefit of novel therapies in multiple myelomaJacob Laubach, Constantine Mitsiades, Kenneth Anderson, et al.
Current Opinion in Oncology|September 22, 2006
Beyond single-agent bortezomib: combination regimens in relapsed multiple myelomaPaul G Richardson, Constantine Mitsiades, Irene Ghobrial, et al.
Annals of Medicine|July 1, 2004
Proteasome inhibition in hematologic malignanciesPaul G Richardson, Teru Hideshima, Constantine Mitsiades, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
The emerging role of novel therapies for the treatment of relapsed myelomaPaul G Richardson, Teru Hideshima, Constantine Mitsiades, et al.
Expert Review of Anticancer Therapy|August 24, 2006
Lenalidomide in multiple myelomaPaul G Richardson, Constantine Mitsiades, Teru Hideshima, et al.
Cell Cycle (Georgetown, Tex.)|January 19, 2005
Proteasome inhibition in the treatment of cancerPaul G Richardson, Constantine Mitsiades, Teru Hideshima, et al.
Annual Review of Medicine|January 18, 2006
Bortezomib: proteasome inhibition as an effective anticancer therapyPaul G Richardson, Constantine Mitsiades, Teru Hideshima, et al.
Molecular Cancer Therapeutics|April 14, 2005
Proteasome inhibitor therapy in multiple myelomaDharminder Chauhan, Teru Hideshima, Constantine Mitsiades, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Future Oncology (London, England)|March 25, 2006
Bortezomib: proteasome inhibition as an effective anticancer therapyPaul G Richardson, Constantine Mitsiades
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
Autologous stem cell transplantation and multiple myeloma cancer stem cellsWilliam Matsui, Ivan Borrello, Constantine Mitsiades
Oncology (Williston Park, N.Y.)|May 30, 2009
Maximizing the clinical benefit of novel therapies in multiple myelomaJacob Laubach, Constantine Mitsiades, Kenneth Anderson, et al.
Current Opinion in Oncology|September 22, 2006
Beyond single-agent bortezomib: combination regimens in relapsed multiple myelomaPaul G Richardson, Constantine Mitsiades, Irene Ghobrial, et al.
Annals of Medicine|July 1, 2004
Proteasome inhibition in hematologic malignanciesPaul G Richardson, Teru Hideshima, Constantine Mitsiades, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
The emerging role of novel therapies for the treatment of relapsed myelomaPaul G Richardson, Teru Hideshima, Constantine Mitsiades, et al.
Expert Review of Anticancer Therapy|August 24, 2006
Lenalidomide in multiple myelomaPaul G Richardson, Constantine Mitsiades, Teru Hideshima, et al.
Cell Cycle (Georgetown, Tex.)|January 19, 2005
Proteasome inhibition in the treatment of cancerPaul G Richardson, Constantine Mitsiades, Teru Hideshima, et al.
Annual Review of Medicine|January 18, 2006
Bortezomib: proteasome inhibition as an effective anticancer therapyPaul G Richardson, Constantine Mitsiades, Teru Hideshima, et al.
Molecular Cancer Therapeutics|April 14, 2005
Proteasome inhibitor therapy in multiple myelomaDharminder Chauhan, Teru Hideshima, Constantine Mitsiades, et al.
Pageof 10